Skip to content

Assessment of Fit of Novel N95 Style Transparent Face Masks

Assessment of User Preference and Fit of Novel Transparent Face Masks

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06570161
Enrollment
0
Registered
2024-08-26
Start date
2024-10-01
Completion date
2025-05-30
Last updated
2025-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Coronavirus, Respiratory Disease, Respiratory Tract Infections

Brief summary

Face masks have become a critically important public health intervention after the COVID-19 pandemic. Multiple types of masks ranging from full face filtering to cloth masks have been developed and commercialized to facilitate protection against respiratory pathogens. Most of these systems are made with opaque fabrics and may prevent individuals from expressing emotions or for those who are deaf and hard of hearing, communicating. To date, few transparent face masks which also confer respiratory pathogen protection have been developed. This study will test the feasability and acceptability of two new masks, the SEEUS-95 mask and CrystalGuard mask which are both transparent versions of N-95 filtering face masks.

Detailed description

This is a randomized crossover trial to evaluate the feasibility, acceptability and choice between the use of the SEEUS-95, CrystalGuard transparent face masks or a standard N95 mask. Otherwise healthy individuals will be prescreened and then scheduled for a single study visit. Participants will be randomized to wear each of the three masks (SEEUS-95, CrystalGuard, N95). They will be taught how to wear the mask, and we will assist participants with correctly wearing the mask for a good fit. Next, participants will undergo standard FIT testing where a clear hood will be placed over the participant's head, and a bitter solution (Bitrex) is sprayed into the hood. A positive test is indicated if the participant is able to taste Bitrex demonstrating that there is a detected leak within the mask. After a few minute washout period, participants will undergo FIT testing of subsequent masks. We will ask participants to rate the comfort of wearing the masks, willingness to wear masks in public and suggestions for improvement in mask design. Finally, we will conduct a discrete choice test to ask participants which mask they would prefer to wear in public.

Interventions

DEVICESEEUS95 Transparent mask

SEEUS95 developed transparent filtering mask

DEVICECrystalGuard Mask

CrystalGuard transparent mask

DEVICEN95 face mask

Standard N95 style face mask

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

Randomized crossover design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \>18 years old * No history of asthma, restrictive lung disease, interstitial lung disease, or emphysema * Lack of significant facial hair that precludes wearing a N-95 mask

Exclusion criteria

* Less than 18 years old * Unable to smell Bitrex solution used for fit testing

Design outcomes

Primary

MeasureTime frameDescription
Acceptabilityimmediately after mask wearingUser acceptability and comfort wearing the assigned mask graded on a likert scale

Secondary

MeasureTime frameDescription
Mask preferenceimmediately after completion of all three armsDiscrete choice of SEEUS-95, CrystalGuard versus standard N-95 mask selected by study participants

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026